Answers are grounded in this paper and cite their sources.
Patients undergoing hemodialysis often present with a reduced response to anti-hepatitis B virus (anti-HBV) vaccination.The soluble form of CD40 (sCD40) is elevated in hemodialysis patients and this has been shown to correlate with lack of response to anti-HBV vaccination.Due to its high molecular weight, conventional dialyzers cannot clear sCD40.Previous studies have demonstrated, that dialysis membranes in polymethylmethacrylate (PMMA) can reduce the levels of sCD40.We have studied the effect of dialysis with PMMA membranes in patients who were non-responders to anti-HBV vaccination after a complete cycle of vaccinations.Interestingly, we found that significantly more patients in the PMMA group were able to mount a response to vaccination, compared to the control group (P = 0.04). Materials and Methods PatientsPatients were included in this study if they had been on maintenance thrice-weekly dialysis treatment and had undergone at least one complete cycle of anti-hepatitis B virus vaccination (20 mg Fendrix, administered at 0, 1, 2 and 6 months) and were non-responders (e.g.anti-HBV antibody titre <10 UI/L).Patients were excluded from this study if they had undergone dialysis treatment with PMMA dialyzers prior to enrolment and/or if they had active neoplasia.All patients gave their informed consent to participate in the study.Following enrolment, patients were randomized into two groups, a control group that continued on the same dialysis treatment as previously, and a treatment group that was shifted to dialysis with PMMA series BK-F (1.3 to 2.1 m 2 ).The treatment with PMMA continued until after the administration of the fourth vaccination.Patients underwent thrice-weekly dialysis for three months and were then administered the fourth vaccination dose.Immune response was evaluated hereafter. Laboratory parametersSerum levels of sCD40 were measured every four weeks by enzyme-linked immunosorbent assay (ELISA) during the 12 weeks of study and again 4 weeks after anti-hepatitis B virus vaccination.ELISA was performed essentially as described by Contin et al. [2], all samples were measured in duplicates and the mean concentration was calculated.Blood urea nitrogen (BUN) concentrations, Kt/V and C-reactive protein (CRP) were evaluated every four weeks.
No takes yet. Share an insight, caveat, or question.
Ennio Duranti (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: